the aid library

LIST OPTIONS

Filter

1936

Sort by:

Direction:

Download (1485)

View PDF (5530)

Psychological first aid: Guide for field workers
recommended

Snider, L.; Van Ommeren, M.; Schafer, A. World Health Organization (WHO) (2011) C_WHO

When terrible things happen in our communities, countries and the world, we want to reach out a helping hand to those who are affected. This guide covers psychological first aid which involves humane, supportive and practical help to fellow human beings suffering serious crisis events. It is writt... more

Download (535)

View PDF (1010)

Cardiovascular Disease, Type 2 Diabetes, Obesity, Cancer, Chronic Obstructive Pulmonary Disease and Hyperlipidaemia Care
recommended

Ministry of Health and Social Welfare, Tanzania Tanzania Diabetes Association (2014) CC

Case Manangement Training Modules

Download (798)

View PDF (1248)

Guideline: Calcium Supplementation In Pregnant Women

World Health Organization (2013)

Download (182)

View PDF (207)

Raport mondial sur le vieillissement et la santé

Organisation mondiale de la Santé (2016) C_WHO

Catalogage à la source : Bibliothèque de l’OMS Rapport mondial sur le vieillissement et la santé. 1.Vieillissement. 2.Espérance de vie. 3.Sujet âgé. 4.Services de santé pour personnes âgées. 5.Santé mondiale. 6.Dynamique des populations. 7.Prestations des soins de santé. I.Organisation... more

Download (4873)

View PDF (2689)

Clinical Management and Referral Guidelines – Volume III: Clinical Guidelines for Management and Referral of Common Conditions at Levels 4–6: Hospitals (Republic of Kenya)

Ministry of Medical Services, Kenya; Ministry of Public Health & Sanitation (2009) C1

Download (54)

View PDF (93)

Планирование и бюджетирование услуг в области психического здоровья

Alan J. Flisher, Michelle Funk, Natalie Drew et al. World Health Organization (2007) C_WHO

Свод методических рекомендаций состоит из нескольких тематически связанных и удобных для пользователя модулей для решения широкого спектра задач и приоритетных ... more

Download (175)

View PDF (355)

Availability and Accessibility of Treatment for Persons with Mental Illness Through a Community Mental Health Programme

Dr. Janardhan N Navaneetham, Shravya Raghunandan, D M Naidu, H Hampanna Disability, CBR & Inclusive Development Journal (DCIDJ) (2011) CC

This article describes experiences in implementing a community mental health and development project in a rural district in southern India, including the position of persons with mental illness when the project was initiated, the challenges faced and the strategies that were developed to overcome th... more

Download (119)

View PDF (256)

C1. Discapacidad intelectual

Xiaoyan Ke & Jing Liu IACAPAP (2015) CC

Download (88)

View PDF (167)

Brief Intervention - The ASSIST-linked brief intervention for hazardous and harmful substance use

R. Humeniuk, S. Henry-Edwards, R. Ali; et al. World Health Organization (2010) C_WHO

Manual for use in primary care

Download (130)

View PDF (1250)

Public perceptions of intellectual disability in a shantytown community in Lima, Peru

M.S. O’Shea, J. M.Girón, L. Cabrera, et al. (2012) CC

Int Health. 2012 December 1; 4(4): 253–259. doi:10.1016/j.inhe.2012.07.001

Download (576)

View PDF (776)

Estratégia Global Aprimorada para reduçâo adicional da carga da Hanseníase (2011-2015)

World Health Organization; Ministério da Saudé, ILSL, et al. (2009)

Download (250)

View PDF (686)

Health in the sustainable development goals: where are we now in the South-East Region? What next?

World Health Organization (WHO), Regional Office for South-East-Asia (2016) C_WHO

Download (119)

View PDF (164)

Troubles somatoformes

O. Fiertag; S. Taylor; A. Tareen; E. Garralda IACAPAP (2017) C2

Psychiatry de l'enfant et pediatrie Chapitre I.1 Edition en français Traduction : Virginie Stalin Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA

Download (1000)

View PDF (3289)

First Aid

Werner, D, et al. Hesperian (2013)

Where there is no doctor Chapter 3

Download (452)

View PDF (1829)

Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended

World Health Organization WHO (2017) C_WHO

Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an... more

Download (351)

View PDF (134)

National guideline for management of Non Communicable Diseases(NCDs)

Rwanda Biomedical Center Ministry of Health Rwanda (2016) CC

Non-Communicable Diseases (NCDs) are a worldwide epidemic. Particularly, the most common diseases - Cardiovascular diseases, Chronic Obstructive Pulmonary Diseases (COPD), Chronic Kidney Diseases, Cancer, Diabetes, injuries and disabilities, EMT, oral, eye g... more

Download (121)

View PDF (152)

Ökonomie und globale Gesundheit

Kohler, S.; M. Roser, P. Geldsetzer, T. Bärnighausen (2021) CC

In: Bonk M., Ulrichs T (eds). Global Health: Das Konzept der Globalen Gesundheit. Berlin: De Gruyter, 2021, pp. 523–556 Wohlstand, Gesundheit und Gesundheitsausgaben sind eng miteinander verknüpft. Im weltweiten Durchschnitt haben alle drei seit vielen Jahren stetig zugenommen. Im Vergleich hab... more

Download (44)

View PDF (256)

Mycetoma: epidemiology, treatment challenges, and progress

Taha, H.; Fahal, A.; Van de Sande, W. Dovepress open access to scientific and medical research (2015) CC

Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de... more

Download (46)

View PDF (303)

The Need for Full Integration of Snakebite Envenoming within a Global Strategy to Combat the Neglected Tropical Diseases: The Way Forward

Gutiérrez, J.; Warrell, D.; Williams, D. et al. PLoS Neglected Tropical diseases (2013) CC

Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Psychological first aid: Guide for field workers recommended

Cardiovascular Disease, Type 2 Diabetes, Obesity, Cancer, Chronic Obstructive Pulmonary Disease and Hyperlipidaemia Care recommended

Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis recommended

Psychological first aid: Guide for field workers
recommended

Cardiovascular Disease, Type 2 Diabetes, Obesity, Cancer, Chronic Obstructive Pulmonary Disease and Hyperlipidaemia Care
recommended

Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended